Synthesis of Biologically Active Natural Products
Synthesis of Biologically Active Natural Products
批准号:
7529205
负责人:
BARRY B. SNIDER
金额:
$28.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 2011-11-30
关键词:
AdhesionsAldehydesAlkaloidsAminesAnhydridesAnti-Bacterial AgentsAntibioticsAntifungal AgentsBacterial DNABiologicalBiological FactorsBiomimeticsCandida albicansCellsChemistryCyclohexanesDNA PrimaseDevelopmentDiaminesDiels Alder reactionDinophyceaeDrug resistanceEpoxy CompoundsEstersEvaluationFaceGram-Positive BacteriaHL-60 CellsHandHumanHydrazineHydrazinesImidesInhibitory Concentration 50Japanese PopulationK-562KetonesLanosterol synthaseLeadLigandsLiverMacrolidesMalignant NeoplasmsMarinesMethodsModelingMono-SOne-Step dentin bonding systemOsteoclastsOsteoporosisPenicilliumPharmaceutical PreparationsPostmenopausePreparationPreventionProlineProtonsRattusReactionReportingRouteSaccharomyces cerevisiaeSaltsSch 642305SeaSodium ChlorideSourceSparteineSqualeneSqualene SynthetaseStreptomycesStructureSystemWomanYeastsanalogazinebasebohemaminecatalystcitronellaldrug candidateepimerizationepohelmin Ainhibitor/antagonistinterestjenamidine Aleukemialipoprotein-associated phospholipase A(2)metermethyl groupnovelphospholipase A2 inhibitorpi bondresistant strainstereochemistry
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposal consists of five unrelated projects to prepare structurally novel, biologically active natural
products of potential interest as drugs and, in carrying out these syntheses, to develop newsynthetic
methods that will be of general interest and utility. (1) Symbioimine, which inhibits osteoclast differentiation
and may therefore be of value in the treatment of osteoporosis, will be synthesized using the novel Diels-
Alder reaction of a dihydropyridinium salt as the key step. (2) The proline-derived alkaloids jenamidine A,
SB-311099, and epohelmins A and B were recently isolated from a variety of sources and have potent
biological activity. New chemistry will be developed to synthesize these natural products to confirm the
assignments and provide material for further biological evaluation. (3) An unusual bicyclic macrolide, Sch
642305 inhibits bacterial DMAprimase with an EC50 of 70 micromolar making it a lead for the development
of new antibacterial agents. A stereochemically simpler macrolide precursor will be prepared and converted
to Sch 642305 by a trans-annular Michael reaction as a novel and potentially very efficient route to this type
ring system. (4) Abyssomicin C shows antibiotic activity against a variety of Gram-positive bacteria
including pathogenic Staphyloccocus aureus strains and drug-resistant strains. A biomimetic synthesis will
be carried out using an intramolecular Diels-Alder reaction to form the cyclohexane ring. Epoxidation and
ring opening of the epoxide will complete the synthesis. (5) Bisabosqual A inhibits the microsomal squalene
syntheses from Saccharomyces cerevisiae, Candida albicans, HepG2 cell and rat liver with IC50 valuesof
0.43, 0.25, 0.95 and 2.5 microgram/mL, respectively, and has broad antifungal activities against various
yeasts. The tetracyclic framework and stereochemistry make the synthesis a challenging problem which will
be carried out using chemistry developed in our synthesis of the tetracyclic core. (6) A C2-Symmetric
hydrazine and the derived C2-symmetric diamine have been prepared in multi-gram quantities from the
azine of citronellal their utility in asymmetric synthesis will be explored. These natural product targets are
leads for the treatment of osteoporosis and cancer and for the development of new antibiotics. In the course
of these studies new methods will be developed that are of general utility for preparing drugs more
economically.
期刊论文(55)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Synthesis of 7-epineoptilocaulin, mirabilin B, and isoptilocaulin. A unified biosynthetic proposal for the ptilocaulin and batzelladine alkaloids. Synthesis and structure revision of netamines E and G.
7-epineoptilocaulin、mirabilin B 和 isoptilocaculin 的合成。
DOI:
10.1021/jo801956w
发表时间:
2008
期刊:
The Journal of organic chemistry
影响因子:
--
作者:
[Yu,Min, Pochapsky,SusanS, Snider,BarryB]
通讯作者:
Snider,BarryB
Synthesis of the isoxazolo[4,3,2-de]phenanthridinone moiety of the parnafungins.
帕那芬净异恶唑并[4,3,2-去]菲啶酮部分的合成。
DOI:
10.1021/ol901054r
发表时间:
2009
期刊:
Organic letters
影响因子:
5.2
作者:
[Zhou,Quan, Snider,BarryB]
通讯作者:
Snider,BarryB
Synthesis of (+/-)-bistellettadine A.
(/-)-双烯啶A的合成。
DOI:
10.1021/ol902895e
发表时间:
2010
期刊:
Organic letters
影响因子:
5.2
作者:
[Yu,Min, Pochapsky,SusanS, Snider,BarryB]
通讯作者:
Snider,BarryB
DOI:
10.1016/j.tet.2011.09.117
发表时间:
2011-12-09
期刊:
Tetrahedron
影响因子:
2.1
作者:
[Yu M, Snider BB]
通讯作者:
Snider BB
DOI:
10.1021/ol200119h
发表时间:
2011-03-04
期刊:
ORGANIC LETTERS
影响因子:
5.2
作者:
[Lin, Hong-Yu, Snider, Barry B.]
通讯作者:
Snider, Barry B.
共 31 条
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:2838610
-
项目类别:
-
资助金额:$17.58万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:2464827
-
项目类别:
-
资助金额:$15.71万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:6329749
-
项目类别:
-
资助金额:$18.63万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:6830172
-
项目类别:
-
资助金额:$27.31万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:6699049
-
项目类别:
-
资助金额:$27.31万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
Synthesis of Biologically Active Natural Products
-
批准号:7155541
-
项目类别:
-
资助金额:$28.6万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:6620989
-
项目类别:
-
资助金额:$27.31万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
Synthesis of Biologically Active Natural Products
-
批准号:7333310
-
项目类别:
-
资助金额:$28.6万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:6429924
-
项目类别:
-
资助金额:$29.53万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
Synthesis of Biologically Active Natural Products
-
批准号:7030535
-
项目类别:
-
资助金额:$29.45万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:6125382
-
项目类别:
-
资助金额:$18.1万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
400 MHZ NMR SPECTROMETER
-
批准号:2040260
-
项目类别:
-
资助金额:$23.36万
-
财政年份:1997
-
负责人:BARRY B. SNIDER
-
依托单位:
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:2187772
-
项目类别:
-
资助金额:$12.66万
-
财政年份:1993
-
负责人:BARRY B. SNIDER
-
依托单位:
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:3309170
-
项目类别:
-
资助金额:$11.19万
-
财政年份:1993
-
负责人:BARRY B. SNIDER
-
依托单位:
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:2187781
-
项目类别:
-
资助金额:$14.25万
-
财政年份:1993
-
负责人:BARRY B. SNIDER
-
依托单位:
SYNTHESIS OF BIOLOGICALLY ACTIVE NATURAL PRODUCTS
-
批准号:2187773
-
项目类别:
-
资助金额:$13.7万
-
财政年份:1993
-
负责人:BARRY B. SNIDER
-
依托单位:
MANGANESE (III) BASED OXIDATIVE FREE RADICAL CYCLIZATION
-
批准号:2183961
-
项目类别:
-
资助金额:$20.7万
-
财政年份:1991
-
负责人:BARRY B. SNIDER
-
依托单位:
MANGANESE (III) BASED OXIDATIVE FREE RADICAL CYCLIZATION
-
批准号:6221444
-
项目类别:
-
资助金额:$6.38万
-
财政年份:1991
-
负责人:BARRY B. SNIDER
-
依托单位:
MANGANESE (III) BASED OXIDATIVE FREE RADICAL CYCLIZATION
-
批准号:2183960
-
项目类别:
-
资助金额:$17.76万
-
财政年份:1991
-
负责人:BARRY B. SNIDER
-
依托单位:
MANGANESE (III) BASED OXIDATIVE FREE RADICAL CYCLIZATION
-
批准号:2183959
-
项目类别:
-
资助金额:$14.25万
-
财政年份:1991
-
负责人:BARRY B. SNIDER
-
依托单位:
海外基金